Regulation of the epidermal growth factor receptor by growth-modulating agents

M R Rosner1

  • 1Ben May Institute, University of Chicago, Illinois 60637.

Insights

Tumor promoters regulate the epidermal growth factor (EGF) receptor through phosphorylation, internalization, and enhanced synthesis. These processes involve calcium and sodium signaling pathways, impacting cell growth and tumor development.

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • The epidermal growth factor (EGF) receptor is a key mediator of cell proliferation and tumorigenesis.
  • EGF receptor activity is tightly regulated by various cellular mechanisms.
  • Understanding these regulatory pathways is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To identify and elucidate the mechanisms by which external agents regulate the EGF receptor.
  • To investigate the role of signaling pathways in EGF receptor modulation.
  • To provide insights into the molecular basis of tumor promotion.

Main Methods:

  • Investigated EGF receptor regulation by heterologous agents, including tumor promoters.
  • Analyzed receptor binding and kinase activity modulation via phosphorylation.
  • Assessed receptor downregulation through internalization and enhanced synthesis via transcriptional activation.
  • Examined the involvement of calcium- and sodium-dependent signaling pathways.

Main Results:

  • Identified three primary mechanisms of EGF receptor regulation by tumor promoters: modulation of binding/kinase activity, receptor downregulation via internalization, and enhanced synthesis through transcriptional activation.
  • Demonstrated that both calcium- and sodium-dependent signaling pathways are implicated in these regulatory processes.
  • Highlighted the complex interplay between growth factors, receptors, and signaling cascades in cellular regulation.

Conclusions:

  • Heterologous agents, such as tumor promoters, exert significant regulatory control over the EGF receptor.
  • Multiple signaling pathways, including calcium and sodium dependent ones, converge to modulate EGF receptor function and expression.
  • These findings offer a deeper understanding of EGF receptor regulation in the context of cell growth and cancer, potentially informing therapeutic strategies.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: